Literature DB >> 20845097

Radiological estimation of size in colorectal liver metastases: is it reliable? Comparison with post-resectional measurements.

Florin Botea1, Matteo Marconi, Fabio Lutman, Luca Balzarini, Massimo Roncalli, Marco Montorsi, Guido Torzilli.   

Abstract

Since the efficiency of percutaneous ablation techniques in treating colorectal liver metastases is dependent on tumor size, the aim of this study was to verify the accuracy of computed tomography or magnetic resonance in estimating the maximum diameter of colorectal liver metastases by comparing these findings with those of pathology in a series of patients who underwent liver resection. Radiological and pathological tumor measurements in 39 patients operated for 69 colorectal liver metastasis were recorded. The radiological measurement was performed by magnetic resonance in 40 tumors (23 cases) and by computed tomography in 29 tumors (16 patients). The mean difference between pathological and radiological sizes was 0.4 cm (p < 0.001). Radiological size was smaller than pathological size in 60.9% of tumors, equal in 16% and bigger in 23% of tumors. The results indicated that radiology significantly underestimates the diameter of liver metastasis. To avoid on-site recurrence after percutaneous ablation therapies due to inaccurate radiological measurement, a radiological size of colorectal metastasis up to 2.5 cm should be considered as selection criteria for this treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20845097     DOI: 10.1007/s13304-010-0004-0

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  26 in total

1.  Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center.

Authors:  U Baccarani; G L Adani; C Avellini; D Lorenzin; G Currò; A Beltrami; A Pasqualucci; V Bresadola; A Risaliti; P L Viale; C A Beltrami; F Bresadola
Journal:  Transplant Proc       Date:  2006-05       Impact factor: 1.066

2.  Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.

Authors:  Danny H F Chow; Lorraine H Y Sinn; Kelvin K Ng; Chi Ming Lam; Jimmy Yuen; Sheung Tat Fan; Ronnie T P Poon
Journal:  J Surg Oncol       Date:  2006-12-01       Impact factor: 3.454

3.  Long-term survival after radiofrequency ablation of complex unresectable liver tumors.

Authors:  Farin F Amersi; Ana McElrath-Garza; Aziz Ahmad; Theresa Zogakis; David P Allegra; Robert Krasne; Anton J Bilchik
Journal:  Arch Surg       Date:  2006-06

4.  Value and limitations of abdominal ultrasound in tumour staging--liver metastasis and lymphoma.

Authors:  J Schölmerich; B A Volk; W Gerok
Journal:  Eur J Radiol       Date:  1987-11       Impact factor: 3.528

5.  Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.

Authors:  T F Wood; D M Rose; M Chung; D P Allegra; L J Foshag; A J Bilchik
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

6.  Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.

Authors:  Chris R Kelsey; Tracey Schefter; S Russell Nash; Paul Russ; Anna E Barón; Chan Zeng; Laurie E Gaspar
Journal:  Am J Clin Oncol       Date:  2005-12       Impact factor: 2.339

7.  Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases.

Authors:  Fredericke H van Duijnhoven; Maarten C Jansen; Jan M C Junggeburt; Richard van Hillegersberg; Arjen M Rijken; Frits van Coevorden; Joost R van der Sijp; Thomas M van Gulik; Gerrit D Slooter; Joost M Klaase; Hein Putter; Rob A E M Tollenaar
Journal:  Ann Surg Oncol       Date:  2006-03-17       Impact factor: 5.344

8.  Clinical and pathologic tumor size in renal cell carcinoma; difference, correlation, and analysis of the influencing factors.

Authors:  Ozgur Yaycioglu; Matthew P Rutman; Mamtha Balasubramaniam; Kenneth M Peters; Jose A Gonzalez
Journal:  Urology       Date:  2002-07       Impact factor: 2.649

9.  The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned.

Authors:  Pui Yee Grace Choy; Jonathan Koea; John McCall; Andrew Holden; Mark Osbourne
Journal:  N Z Med J       Date:  2002-08-09

10.  Percutanous and intraoperative ultrasound-guided radiofrequency ablation of hepatic tumours.

Authors:  A Stang; H Keles; C von Seydewitz; S Hentschke; E Malzfeldt; W Teichmann; D Braumann
Journal:  Ultraschall Med       Date:  2007-04       Impact factor: 6.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.